{
    "Trade/Device Name(s)": [
        "Rightest Blood Glucose Monitoring System Wiz",
        "Rightest Blood Glucose Monitoring System Wiz Plus"
    ],
    "Submitter Information": "Bionime Corporation",
    "510(k) Number": "K173139",
    "Predicate Device Reference 510(k) Number(s)": [
        "K170143"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW"
    ],
    "Summary Letter Date": "May 15, 2018",
    "Summary Letter Received Date": "May 18, 2018",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [
        ""
    ],
    "Instrument(s)/Platform(s)": [
        "Rightest Blood Glucose Meter Wiz",
        "Rightest Blood Glucose Meter Wiz Plus"
    ],
    "Method(s)/Technology(ies)": [
        "Glucose Oxidase Electrochemical Sensor"
    ],
    "Methodologies": [
        "Electrochemical measurement"
    ],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test Strip",
        "Control Solution",
        "Lancing Device",
        "Lancet"
    ],
    "Document Summary": "FDA 510(k) summary for Bionime Rightest Blood Glucose Monitoring System Wiz and Wiz Plus for quantitative measurement of glucose in capillary whole blood",
    "Indications for Use Summary": "Intended for self-testing by individuals with diabetes at home, measuring glucose in fresh capillary whole blood from fingertip, forearm, or palm; not for diagnosis, screening, or neonatal use",
    "fda_folder": "Clinical Chemistry"
}